| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ca-170 | programmed cell death 1 ligand 1 | small molecule | Successful target | TTD , drugbank , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Hippocampus Proper[MeSHID:D006624] Lymphoma[MeSHID:D008223] |
NA | investigational,phase 1 | inhibitor |
| ca-170 | v-set immunoregulatory receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Hippocampus Proper[MeSHID:D006624] Lymphoma[MeSHID:D008223] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||